2022 annual financial data

CNS Pharmaceuticals 2022 Financial results

Direct answer

Revenue was 0 USD.

Operating income was -14,932,969 USD and net income was -15,274,134 USD.
Operating cash flow was -10,557,815 USD.

Get free CNS Pharmaceuticals email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
0 USD
Operating income
-14,932,969 USD
Net income
-15,274,134 USD
Operating cash flow
-10,557,815 USD